Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
4.6%
% of FHLC's 369 holdings also in PPH
66.7%
% of PPH's 27 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 12.4% | 10.2% |
|
JOHNSON & JOHNSON | 6.1% | 6.4% | 6.1% |
|
ABBVIE INC | 5.2% | 5.9% | 5.2% |
|
MERCK & CO. INC. | 5.0% | 5.0% | 5.0% |
|
PFIZER INC | 2.7% | 4.3% | 2.7% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to PPH
|
UNITEDHEALTH GROUP INC | 8.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
DANAHER CORP | 3.0% |
|
ABBOTT LABORATORIES | 2.9% |
|
AMGEN INC | 2.8% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
|
ELEVANCE HEALTH INC | 1.9% |
|
REGENERON PHARMACEUTICALS | 1.8% |
|
STRYKER CORP | 1.8% |
FHLC Underweight Relative to PPH
 |
NOVO-NORDISK A/S-SPONS ADR | -8.1% |
 |
NOVARTIS AG-ADR | -4.7% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.5% |
|
MCKESSON CORP | -4.4% |
|
AMERISOURCEBERGEN CORP | -4.2% |
|
BRISTOL-MYERS SQUIBB CO | -4.1% |
 |
SANOFI-AVENTIS-ADR | -4.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.9% |
 |
TEVA PHARMACEUTICAL-SP ADR | -3.6% |